SAN ANTONIO--(BUSINESS WIRE)--CeloNova BioSciences, Inc. (CeloNova) today announced that it has received U.S. Food and Drug Administration (FDA) approval of its first-in-class COBRA PzF™ NanoCoated ...
CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System
SAN ANTONIO., CeloNova BioSciences, Inc. announced today that it has received conditional approval to start an investigational device exemption (IDE) trial to study the COBRA PzF coronary stent system ...
SAN ANTONIO. -- CeloNova BioSciences, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted approval to start an investigative device exemption (IDE) trial for its novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results